Skip to content

BioCorRx Inc.

BICX

CIK 0001443863

← back to feed
Revenue (TTM)
$1.16M
+10,301.1% YoY Q1 May 2026
Net Income (TTM)
−$4.82M
+32.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$0.27
+61.2% YoY Q1 May 2026
Gross Margin
79.2%
Q1 May 2026
Operating Margin
-451.8%
Q1 May 2026
Net Margin
-414.8%
Q1 May 2026
Free Cash Flow (TTM)
−$1.86M
Q1 May 2026
Cash
$111.46K
Q1 May 2026
Total Debt
$0
Q1 May 2026
Shares Outstanding
29.06M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings